AML-262 Pivekimab Sunirine (PVEK, IMGN632) Triplet With Azacitidine and Venetoclax Shows Broad Activity in Adverse Genetic Subsets of Relapsed/Refractory Acute Myeloid Leukemia and Reduced Infusion-Related Reactions (2022)

First Author: Daver N
Attributed to:  University of Oxford – Confidence in Concept 2019 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2152-2650(22)01257-5

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85138157209

Type: Journal Article/Review

Parent Publication: Clinical Lymphoma Myeloma and Leukemia